Skip to content

Clinical trials

Phase 2 Stomach Neoplasms trials in Russia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Stomach Neoplasms Phase: Phase 2 Country / region: Russia Clear all

15 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20062
20081
20101
20121
20141
20151
20171
20181
20192
20201
20231
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed7
Active, not recruiting2
Recruiting2
Terminated2
Enrolling by invitation1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca2
Blokhin's Russian Cancer Research Center2
Eli Lilly and Company2
Amgen1
Apollomics Inc.1
BeiGene1
GlaxoSmithKline1
Hoffmann-La Roche1
Merck Sharp & Dohme LLC1
Nizhny Novgorod Regional Clinical Oncology Center1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Stomach Neoplasms15
Colorectal Neoplasms2
Glioblastoma2
Pancreatic Neoplasms2
Adenocarcinoma1
Biliary Tract Neoplasms1
Brain Neoplasms1
Breast Neoplasms1
Carcinoma1
Colonic Neoplasms1

Trials

Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.